Phosphorus Dysregulation and Cardiovascular Events in Hemodialysis Patients

Yang, S. S., Lin, S. H., Tsai, W. S., Juang, J. G., & Lin, Y. F. (2002). Evaluation of Metabolic Acidosis in Chronic Hemodialysis Patients. Journal of Medical Sciences, 22(4), 165-169. https://www.airitilibrary.com/Article/Detail?DocID=10114564-200208-201305090025-201305090025-165-169
Wu, P. H. (2015). The effect of cardiovascular prevention drugs in dialysis patients [master's thesis, Kaohsiung Medical University]. Airiti Library. https://doi.org/10.6832/KMU.2015.00115
黃湘茹（2015）。The Incidence of Cardivascular Disease and Related Factors in Hemodialysis Patients〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2015.01879
Sande, F. V. D., Kooman, J., & Leunissen, K. (2006). The Complex (Patho) Physiology of Cardiovascular Responses to Hemodialysis and Ultrafiltration. Acta Nephrologica, 20(2), 81-87. https://www.airitilibrary.com/Article/Detail?DocID=10131671-200604-20-2-81-87-a
Juan, Y. T., Wu, H. Y., Chiu, Y. L., Yang, J. Y., Pai, M. F., Hsu, S. P., Peng, Y. S., Lai, Y. C., Luan, C. C., & Tsai, W. C. (2021). Factors Associated with Compliance to Low Phosphate Diets in Hemodialysis Patients with Uncontrolled Hyperphosphatemia. Acta Nephrologica, 35(3), 126-134. https://doi.org/10.6221/AN.202109_35(3).0003